共 14 条
[1]
Postmenopausal hormone therapy increases risk for venous thromboembolic disease.The Heart and Estrogen/progestin Replacement Study. Grady D,Wenger NK,Herrington D,et al. Annals of Internal Medicine . 2000
[2]
Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Mosca L,Collins P,Herrington DM,et al. Circulation . 2001
[3]
The AHA guidelines on hormone replacement therapy and cardiovascular diseases. Burger H,Teede H. Maturitas . 2001
[4]
The AHA guidelines on hormone replacement therapy and cardiovascular diseases. Burger H,Teede H. Maturitas . 2001
[5]
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. Alexander KP,Newby LK,Hellkamp AS,et al. Journal of the American College of Cardiology . 2001
[6]
The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Grodstein F,Stampfer M. Progress in Cardiovascular Diseases . 1995
[7]
Reduced mortality associated with long-term postmenopausal estrogen therapy. Ettinger B,Friedman GD,Bush T,et al. Obstetrics and Gynecology . 1996
[8]
A prospective observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Grodstein F,Manson JE,Colditz GA,et al. Annals of Internal Medicine . 2000
[9]
Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen/progestin Replacement Study(HERS). Simon JA,Hsia J,Cauley JA,et al. Circulation . 2001
[10]
Controversial issues in climacteric medcine ( Ⅰ)cardiovascular disease and hormone replacement therapy.International Menopause Society Expert Workshop, 13-16 October 2000, Royal Society of Medcine, London, UK. Genazzani AR. Maturitas . 2001